Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Cian Healthcare Ltd - 542678 - Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On Tuesday, 30Th May, 2023 For Consider And Approve The Audited Financial Results (Standalone And Consolidated).

 Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve Meeting of the Board of Directors of the Company scheduled to be held on Tuesday, 30th May, 2023, inter-alia, to consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the half year and year ended March 31st, 2023.
24-05-2023
Bigul

Cian Healthcare Ltd - 542678 - DECLARATION OF REMOTE E- VOTING AND POLL VOTING RESULTS IN COMPLIANCE WITH REGULATION 44 (3) OF SEBI (LODR) REGULATIONS, 2015

 DECLARATION OF REMOTE E- VOTING AND POLL VOTING RESULTS IN COMPLIANCE WITH REGULATION 44 (3) OF SEBI (LODR) REGULATIONS, 2015
19-05-2023
Bigul

Cian Healthcare Ltd - 542678 - Announcement under Regulation 30 (LODR)-Meeting Updates

 Proceeding of the 01st Extra-Ordinary General Meeting for the financial year 2023-24 of Cian Healthcare Limited held on Saturday 13th May, 2023.
13-05-2023
Bigul

Cian Healthcare Ltd - 542678 - OUTCOMES OF THE EXTRA-ORDINARY GENERAL MEETING HELD ON SATURDAY 13TH MAY, 2023.

 OUTCOMES OF THE EXTRA-ORDINARY GENERAL MEETING HELD ON SATURDAY 13TH MAY, 2023.
13-05-2023
Bigul

Cian Healthcare Ltd - 542678 - Intimation Of Facilities Audit Conducted By Sun Pharmaceutical Industries Limited For Procurement Of Indigenous Developed Veterinary Products Pursuant To Regulation 30(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Intimation of Facilities Audit Conducted by Sun Pharmaceutical Industries Limited for Procurement of indigenous developed veterinary products pursuant to Regulation 30(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
06-05-2023
Bigul

Cian Healthcare Ltd - 542678 - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Intimation Of Receipt Of Registration And Approvals For Export Of Multiple Products Of Company

 Announcement under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Intimation of receipt of Registration and approvals for Export of multiple products of Company
06-05-2023
Bigul

Cian Healthcare Ltd - 542678 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)

 Intimation of case filed against Cian Healthcare Limited ('the Company') under Section 8 of Insolvency and Bankruptcy Code, 2016
06-05-2023
Bigul

Cian Healthcare Ltd - 542678 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyCian Healthcare Ltd 2CIN NO.L24233PN2003PLC017563 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 12.07 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: MUNJAJI DHUMAL Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Riyaz Bashir Khan Designation: Chief Financial Officer EmailId: [email protected] Date: 28/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
28-04-2023
Bigul

Cian Healthcare Ltd - 542678 - Submission Of Certificate Of Compliance Report For The Year Ended On 31St March, 2023 Under Regulation 40(9) & (10) Of SEBI (LODR) Regulations, 2015.

 Submission of Certificate of Compliance Report for the Year ended on 31st March, 2023 Under regulation 40(9) & (10) of SEBI (LODR) Regulations, 2015.
27-04-2023
Bigul

Cian Healthcare Ltd - 542678 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 SUBMISSION OF NEWSPAPER ADVERTISEMENT ABOUT NOTICE OF EOGM, REMOTE E-VOTING AND DISPATCH OF NOTICE
21-04-2023
Next Page
Close

Let's Open Free Demat Account